Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
B. K. Patel, S. H. D. Jackson, C. G. Swift & A. J. Hutt. (2003) Disposition of flurbiprofen in man: influence of stereochemistry and age. Xenobiotica 33:10, pages 1043-1057.
Read now
Read now
B. C. Mayo, L. F. Chasseaud, D. R. Hawkins, I. W. Taylor & J. Legeai. (1990) The metabolic fate of 14C-ximoprofen in rats, baboons and humans. Xenobiotica 20:3, pages 233-246.
Read now
Read now
A. L. Servin, D. Wicek, M. P. Oryszczyn, C. Jacquot, J. P. Lussiana, H. Christinaki & C. Viel. (1987) Metabolism of 6,7-dimethoxy 4-(4′-chlorobenzyl)isoquinoline. II. Role of liver catechol O-methyltransferase and glutathione. Xenobiotica 17:12, pages 1381-1391.
Read now
Read now
Bruce Clark, Dennis A. Smith & John Caldwell. (1984) Pharmacokinetics and Toxicity Testing. CRC Critical Reviews in Toxicology 12:4, pages 343-385.
Read now
Read now
M. Rosenthal. (1984) The efficacy of flurbiprofen versus piroxicam in the treatment of acute soft tissue rheumatism. Current Medical Research and Opinion 9:5, pages 304-309.
Read now
Read now
M. Orme, N. Baber, J. Keenan, L. Halliday, R. Sibeon & T. Littler. (1981) Pharmacokinetics and Biochemical Effects in Responders and Non-Responders to Non-Steroidal Anti-Inflammatory Drugs. Scandinavian Journal of Rheumatology 10:sup39, pages 19-27.
Read now
Read now
Articles from other publishers (59)
Maxime Cambournac, Yann Moumadah, Philippe Berny & Bernadette España. (2022) Treatment of flurbiprofen overdose with therapeutic plasma exchange in a dog. Veterinary Record Case Reports 11:1.
Crossref
Crossref
Fabio Bachmann, Urs Duthaler & Stephan Krähenbühl. (2021) Effect of deglucuronidation on the results of the Basel phenotyping cocktail. British Journal of Clinical Pharmacology 87:12, pages 4608-4618.
Crossref
Crossref
Mehmet Emrah Yaman, Alptug Atila, Tugrul Cagri Akman, Mevlut Albayrak, Yucel Kadioglu & Zekai Halici. (2021) A Sensitive UPLC-MS/MS Method for the Determination of Flurbiprofen in Rat Plasma: Application to Real Sample. Journal of Chromatographic Science 59:6, pages 502-509.
Crossref
Crossref
Sandhyarani Guggilla, Middela Karthik & Boini Shylendra. 2021. GeNeDis 2020. GeNeDis 2020
59
63
.
Ioannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Masoud Jamei, David Turner & Jennifer Dressman. (2020) Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. Pharmaceutics 12:11, pages 1049.
Crossref
Crossref
Kadir Yanaç & Robert W. Murdoch. (2019) Biotransformation of the Fluorinated Nonsteroidal Anti‐Inflammatory Pharmaceutical Flurbiprofen in Activated Sludge Results in Accumulation of a Recalcitrant Fluorinated Aromatic Metabolite. Global Challenges 3:6.
Crossref
Crossref
Babiker El-Haj, Samrein Ahmed, Mousa Garawi & Heyam Ali. (2018) Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity. Molecules 23:9, pages 2119.
Crossref
Crossref
Tadatoshi Tanino, Yoshinori Funakami, Noriaki Nagai & Yoshihisa Kato. (2015) Cyclosporin A-sensitive cytotoxicity of flurbiprofen non-stereoselectively mediated by cytochrome P450 metabolism in three-dimensional cultured rat hepatocytes. Journal of Pharmacy and Pharmacology 67:10, pages 1406-1415.
Crossref
Crossref
Oscar Sasso, Marco Migliore, Damien Habrant, Andrea Armirotti, Clara Albani, Maria Summa, Guillermo Moreno‐Sanz, Rita Scarpelli & Daniele Piomelli. (2015) Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage. The FASEB Journal 29:6, pages 2616-2627.
Crossref
Crossref
Yun-Jeong Lee, Ji-Yeong Byeon, Young-Hoon Kim, Se-Hyung Kim, Chang-Ik Choi, Jung-Woo Bae, Uy-Dong Sohn, Choon-Gon Jang, Jeongmi Lee & Seok-Yong Lee. (2015) Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects. Archives of Pharmacal Research 38:6, pages 1232-1237.
Crossref
Crossref
Jessica Karlsson & Christopher J. Fowler. (2014) Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen. PLoS ONE 9:7, pages e103589.
Crossref
Crossref
Alaa A.-M. Abdel-Aziz, Abdullah A. Al-Badr & Gamal Abdel Hafez. 2012.
113
181
.
Jessica Amadio, Katherine Gordon & Cormac D. Murphy. (2010)
Biotransformation of Flurbiprofen by
Cunninghamella
Species
. Applied and Environmental Microbiology 76:18, pages 6299-6303.
Crossref
Crossref
L Igarza, A Soraci, N Auza & H Zeballos. (2006) Pharmacokinetic Parameters of (R)-(−) and (S)-(+)-Flurbiprofen in Dairy Bovines. Veterinary Research Communications 30:5, pages 513-522.
Crossref
Crossref
A. David Rodrigues. (2005)
IMPACT OF
CYP2C9
GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?: TABLE 1
. Drug Metabolism and Disposition 33:11, pages 1567-1575.
Crossref
Crossref
Bhavesh K. Patel, Melissa Hanna-Brown, Mark R. Hadley & Andrew J. Hutt. (2004) Enantiomeric resolution of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs by capillary electrophoresis: Methods and applications. ELECTROPHORESIS 25:16, pages 2625-2656.
Crossref
Crossref
Makiko Shimizu, Reiko Matsushita, Yoshiaki Matsumoto & Masamichi Fukuoka. (2003) 4'-Hydroxylation of Flurbiprofen by Rat Liver Microsomes in Fasting and Feeding Conditions. Biological and Pharmaceutical Bulletin 26:10, pages 1448-1454.
Crossref
Crossref
B. K. Patel, J. Valentova & A. J. Hutt. (2003) Stereospecific analysis of flurbiprofen and its major metabolites in plasma and urine by chiral-phase liquid chromatography. Chromatographia 57:1-2, pages 7-18.
Crossref
Crossref
Tomoaki Nagao, Tadatoshi Tanino & Masahiro Iwaki. (2003) Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant‐induced arthritic rats. Chirality 15:5, pages 423-428.
Crossref
Crossref
B. K. Patel, J. Valentova & A. J. Hutt. (2002) Chromatographic separation and enantiomeric resolution of flurbiprofen and its major metabolites. Chromatographia 55:3-4, pages 135-142.
Crossref
Crossref
J.Matthew Hutzler, Reginald F. Frye, Kenneth R. Korzekwa, Robert A. Branch, S.-M. Huang & Timothy S. Tracy. (2001) Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone. European Journal of Pharmaceutical Sciences 14:1, pages 47-52.
Crossref
Crossref
Vaishali V Dhavse, D.V Parmar & Padma V Devarajan. (1997) High-performance thin-layer chromatographic determination of flurbiprofen in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 694:2, pages 449-453.
Crossref
Crossref
M. Yabuki, J. Shimakura, M. Ito, H. Kanamaru, K. Iba & I. Nakatsuka. (1997) Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849) in rats. European Journal of Drug Metabolism and Pharmacokinetics 22:1, pages 25-33.
Crossref
Crossref
A. Mukherjee, V. G. Hale, O. Borga & R. Stein. (1996) Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats. Inflammation Research 45:11, pages 531-540.
Crossref
Crossref
Timothy S. Tracy, Christina Marra, Steven A. Wrighton, Frank J. Gonzalez & Kenneth R. Korzekwa. (1996) Studies of Flurbiprofen 4′-Hydroxylation. Biochemical Pharmacology 52:8, pages 1305-1309.
Crossref
Crossref
D K Mishra, J Fridén, M C Schmitz & R L Lieber. (1995) Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function.. The Journal of Bone & Joint Surgery 77:10, pages 1510-1519.
Crossref
Crossref
Timothy S. Tracy, Brady W. Rosenbluth, Steven A. Wrighton, Frank J. Gonzalez & Kenneth R. Korzekwa. (1995) Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)- and (S)-flurbiprofen. Biochemical Pharmacology 49:9, pages 1269-1275.
Crossref
Crossref
A. M. Taburet, E. Singlas, R. C. Glass, F. Thomas & E. Leutenegger. (1995) Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics 20:2, pages 101-107.
Crossref
Crossref
TS Tracy, T. Worster, JD Bradley, PK Greene & DC Brater. (2012) Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.. British Journal of Clinical Pharmacology 37:5, pages 453-456.
Crossref
Crossref
M. Spraul, M. Hofmann, I.D. Wilson, E. Lenz, J.K. Nicholson & J.C. Lindon. (1993) Coupling of HPLC with 19F- and 1H-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites. Journal of Pharmaceutical and Biomedical Analysis 11:10, pages 1009-1015.
Crossref
Crossref
MP Knadler, DC Brater & SD Hall. (2012) Stereoselective disposition of flurbiprofen in uraemic patients.. British Journal of Clinical Pharmacology 33:4, pages 377-383.
Crossref
Crossref
MP Knadler, DC Brater & SD Hall. (2012) Stereoselective disposition of flurbiprofen in normal volunteers.. British Journal of Clinical Pharmacology 33:4, pages 369-375.
Crossref
Crossref
G. Geisslinger, S. Menzel-Soglowek, O. Schuster & K. Brune. (1992) Stereoselective high-performance liquid chromatographic determination of flurbiprofen in human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 573:1, pages 163-167.
Crossref
Crossref
Walter F. Kean, Edward J. Antal, Eileen M. Grace, Henriette Cauvier, Janice Rischke & Watson W. Buchanan. (1992) The Pharmacokinetics of Flurbiprofen in Younger and Elderly Patients with Rheumatoid Arthritis. The Journal of Clinical Pharmacology 32:1, pages 41-48.
Crossref
Crossref
Eugenio A. Cefali, Wesley J. Poynor, Domenic Sica & Steven Cox. (1991) Pharmacokinetic Comparison of Flurbiprofen in End-Stage Renal Disease Subjects and Subjects with Normal Renal Function. The Journal of Clinical Pharmacology 31:9, pages 808-814.
Crossref
Crossref
ø Hundal & HE Rugstad. (2009) Determination of free concentration of piroxicam and naproxen in plasma. The influence of experimental conditions in equilibrium dialysis. Fundamental & Clinical Pharmacology 5:4, pages 275-283.
Crossref
Crossref
J. H. Kreeft, N. Bellamy, D. Freeman & J. Campbell. (1991) Interaction between flurbiprofen and H2-antagonists in rheumatoid arthritis. Inflammopharmacology 1:2, pages 135-142.
Crossref
Crossref
Ralph E. Small PharmD, Steven R. Cox & Wade J. Adams. (1990)
Influence of H
2
Receptor Antagonists on the Disposition of Flurbiprofen Enantiomers
. The Journal of Clinical Pharmacology 30:7, pages 660-664.
Crossref
Crossref
K.E. Wade, I.D. Wilson, J.A. Troke & J.K. Nicholson. (1990) 19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: Application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid]. Journal of Pharmaceutical and Biomedical Analysis 8:5, pages 401-410.
Crossref
Crossref
Karl-Heinz BeyerKarl-Heinz Beyer. 1990. Biotransformation der Arzneimittel. Biotransformation der Arzneimittel
263
264
.
G. Caillé, P. du Souich, M. Vézina, S. R. Pollock & D. J. Stalker. (2006) Pharmacokinetic interaction between flurbiprofen and antacids in healthy volunteers. Biopharmaceutics & Drug Disposition 10:6, pages 607-615.
Crossref
Crossref
H. Friedman, C. E. Seckman, J. H. Schwartz, F. L. Lanza, G. L. Royer & C. M. Stubbs. (2013) The Effects of Flurbiprofen, Aspirin, Cimetidine, and Antacids on the Gastric and Duodenal Mucosa of Normal Volunteers. An Endoscopic and Photographic Study. The Journal of Clinical Pharmacology 29:6, pages 559-562.
Crossref
Crossref
Iain J. Smith, James L. Hinson, Virginia A. Johnson, R. Don Brown, Sally M. Cook, Robert T. Whitt & John T. Wilson. (1989) Flurbiprofen in Post-Partum Women: Plasma and Breast Milk Disposition. The Journal of Clinical Pharmacology 29:2, pages 174-184.
Crossref
Crossref
M.P. Knadler & S.D. Hall. (1989) High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urine. Journal of Chromatography B: Biomedical Sciences and Applications 494, pages 173-182.
Crossref
Crossref
Fakhreddin Jamali, Brian W. Berry, Morteza R. Tehrani & Anthony S. Russell. (1988) Stereoselective pharmacokinetics of flurbiprofen in humans and rats. Journal of Pharmaceutical Sciences 77:8, pages 666-669.
Crossref
Crossref
A. Bye, W. Adams & D. Kaiser. 1988. Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular. Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular
97
105
.
Steven R. Cox & Kristi K. Forbes. (2012) Excretion of Flurbiprofen into Breast Milk. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 7:6, pages 211-215.
Crossref
Crossref
Diane D. -S. Tang-Liu & Sandra Liu. (1987) Relationship between the ocular and systemic disposition of flurbiprofen: The effect of altered protein dynamics at steady state. Journal of Pharmacokinetics and Biopharmaceutics 15:4, pages 387-397.
Crossref
Crossref
G. J. Szpunar, K. S. Albert, G. G. Bole, J. N. Dreyfus, G. F. Lockwood & J. G. Wagner. (2006) Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships. Biopharmaceutics & Drug Disposition 8:3, pages 273-283.
Crossref
Crossref
David G. Kaiser, Carter D. Brooks & Pavel L. Lomen. (1986) Pharmacokinetics of flurbiprofen. The American Journal of Medicine 80:3, pages 10-15.
Crossref
Crossref
J. A. Vale & T. J. Meredith. (2012) Acute Poisoning Due to Non-Steroidal Anti-Inflammatory Drugs. Medical Toxicology 1:1, pages 12-31.
Crossref
Crossref
Charles C. Marsh, Arthur A. Schuna & Walter R. Sundstrom. (2012) A Review of Selected Investigational Nonsteroidal Antiinflammatory Drugs of the 1980s. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 6:1, pages 10-25.
Crossref
Crossref
Virginia A. Johnson & John T. Wilson. (1986) Flurbiprofen analysis in plasma and breast milk by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 382, pages 367-371.
Crossref
Crossref
Pamela Girgis Takla, Stephen G. Schulman & John H. Perrin. (1985) Measurement of flurbiprofen—human serum albumin interaction by fluorimetry. Journal of Pharmaceutical and Biomedical Analysis 3:1, pages 41-50.
Crossref
Crossref
K.S. Albert, W.R. Gillespie, A. Raabe & M. Garry. (1984) Determination of Flurbiprofen in Human Serum by Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection. Journal of Pharmaceutical Sciences 73:12, pages 1823-1825.
Crossref
Crossref
C. Scaroni, P. L. Mazzoni, E. D'Amico, C. Benvenuti & I. D. Hind. (1984) Pharmacokinetics of oral and rectal flurbiprofen in children. European Journal of Clinical Pharmacology 27:3, pages 367-369.
Crossref
Crossref
A. S.J. P. A.M. VAN MIERT, H. VAN GOGH, I. D. HIND & P. BRESLOFF. (2008) Some pharmacokinetic data of flurbiprofen in the goat. Journal of Veterinary Pharmacology and Therapeutics 6:4, pages 315-317.
Crossref
Crossref
R.J. Minns & D.S. Muckle. (1982) Mechanical properties of traumatized rat tendo-achilles and the effect of an anti-inflammatory drug on the repair properties. Journal of Biomechanics 15:10, pages 783-787.
Crossref
Crossref
B.G. Snider, L.J. Beaubien, D.J. Sears & P.D. Rahn. (1981) Determination of Flurbiprofen and Ibuprofen in Dog Serum with Automated Sample Preparation. Journal of Pharmaceutical Sciences 70:12, pages 1347-1349.
Crossref
Crossref